Funding for this research was provided by:
Medicinska Fakulteten, Lunds Universitet
Vetenskapsrådet
Alfred Österlunds Stiftelse
Lund University
Article History
Received: 29 May 2023
Revised: 25 July 2023
Accepted: 23 August 2023
First Online: 28 August 2023
Declarations
:
: This study received ethical approval from the Lund University Ethical Review Committee (Dnr 2011–432 and 2014–276) and performed in accordance with the Declaration of Helsinki. We used anonymised information from national and regional registers and the need for individual informed consent was waived by the Lund University Ethical Review Committee. Information about the project was advertised in the major newspapers where a possibility to opt-out was offered. This is a principle used in Sweden for population-wide studies using non-identifiable register data.
: AK acts as a part-time (7.5% FTE) scientific advisor for Arthro Therapeutics providing digital treatment for musculoskeletal pain. ME declares consultancy for Cellcolabs AB and Key2Compliance AB. AD declares no conflict of interest.